5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
-24.81%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$397M
AUM Growth
+$397M
(-28%)
Cap. Flow
+$25.8M
Cap. Flow
% of AUM
6.49%
Top 10 Holdings %
Top 10 Hldgs %
98.06%
Holding
13
New
2
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
|
$25.5M |
| 2 |
Janux Therapeutics
JANX
|
$11.1M |
Top Sells
| 1 |
Arvinas
ARVN
|
$7.7M |
| 2 |
Aprea Therapeutics
APRE
|
$3.16M |
Sector Composition
| 1 | Healthcare | 99.08% |
| 2 | Financials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vor Biopharma
VOR
$250M
| $125M | 31.41% | 6,692,429 | – | – |
|
|
AKUS
2
DELISTED
Akouos, Inc. Common Stock
AKUS
| $51.9M | 13.06% | 4,135,784 | – | – |
|
3
IDEAYA Biosciences
IDYA
$2.15B
| $37.7M | 9.5% | 1,798,066 | – | – |
|
4
Q32 Bio
QTTB
$20.9M
| $33M | 8.3% | 4,535,919 | – | – |
|
|
5
Arvinas
ARVN
$568M
| $30.8M | 7.75% | 400,000 -100,000 | -20% | -$7.7M |
|
6
Crinetics Pharmaceuticals
CRNX
$2.92B
| $25.7M | 6.46% | 1,362,286 | – | – |
|
7
Cabaletta Bio
CABA
$133M
| $25.7M | 6.46% | 2,984,263 | – | – |
|
|
IMPL
8
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $25.5M | 6.43% | +2,884,791 | New | +$25.5M |
|
9
scPharmaceuticals
SCPH
$295M
| $23.4M | 5.89% | 3,831,474 | – | – |
|
|
10
Janux Therapeutics
JANX
$1.37B
| $11.1M | 2.8% | +446,266 | New | +$11.1M |
|
11
Cidara Therapeutics
CDTX
$1.66B
| $4.05M | 1.02% | 2,006,511 | – | – |
|
|
FVAM
12
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
| $3.64M | 0.92% | 365,126 | – | – |
|
|
13
Aprea Therapeutics
APRE
$9.09M
| – | – | -619,157 | Closed | -$3.16M |
|